Overview
Dexamedatomidine vs. Dexamethasone in Rhomboidal Intercostal Plain Block and Subserratus Block in Breast Surgery
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2022-11-15
2022-11-15
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to evaluate the analgesic efficacy and safety of adding dexmedetomidine and dexamethasone to bupivacaine in rhomboidal intercostal and subserratus (RISS) block for patients undergoing modified radical mastectomy compared to bupivacaine only.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Armed Forces College of Medicine, Cairo, EgyptTreatments:
Dexamethasone
Criteria
Inclusion Criteria:- Adult female patient
- Type of surgery; Modified Radical Mastectomy (MRM).
- Physical status ASA II, III.
- Age ≥ 21 and ≤ 65 Years.
- Body mass index (BMI): > 20 kg/m2 and < 35 kg/m2.
Exclusion Criteria:
- Patient refusal.
- Patients suffering from coagulation disorders.
- Patients with histories of allergic reactions to local anesthetics or dexmedetomidine.
- Patients suffering from neuropsychiatric disorders.
- Pregnancy.